Vaxart's Q3 Revenue Jumps 133% to $4.9M, Narrows Losses Amid COVID Trial Progress | VXRT Stock News
StockTitan - 13 Nov 2024Vaxart's Q3 Revenue Jumps 133% to $4.9M, Narrows Losses Amid COVID Trial Progress | VXRT Stock News ...
vxrt stock
Vaxart's Q3 Revenue Jumps 133% to $4.9M, Narrows Losses Amid COVID Trial Progress | VXRT Stock News ...
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance - 13 Nov 2024VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates ...
Earnings Preview For Vaxart
Benzinga - 12 Nov 2024Earnings Preview For Vaxart ...
Vaxart, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Marketscreener.com - 15 Nov 2024Vaxart, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 ...
Vaxart Ends Sales Agreement, Halts Stock Offering
TipRanks - 08 Oct 2024Vaxart Ends Sales Agreement, Halts Stock Offering ...
There's Reason For Concern Over Vaxart, Inc.'s (NASDAQ:VXRT) Massive 39% Price Jump
Simply Wall St - 20 Aug 2024There's Reason For Concern Over Vaxart, Inc.'s (NASDAQ:VXRT) Massive 39% Price Jump ...
Vaxart (NASDAQ:VXRT) Stock Price Passes Below Two Hundred Day Moving Average - Time to Sell?
MarketBeat - 01 Nov 2024Vaxart (NASDAQ:VXRT) Stock Price Passes Below Two Hundred Day Moving Average - Time to Sell? ...
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
StockTitan - 15 Oct 2024Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need ...
VAXART, INC. (VXRT) Reports Q2 Loss, Misses Revenue Estimates
Yahoo Finance - 08 Aug 2024VAXART, INC. (VXRT) Reports Q2 Loss, Misses Revenue Estimates ...
Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding (NASDAQ:VXRT)
Seeking Alpha - 27 Jun 2024Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding (NASDAQ:VXRT) ...
While shareholders of Vaxart (NASDAQ:VXRT) are in the black over 5 years, those who bought a week ago aren't so fortunate
Simply Wall St - 05 Nov 2024While shareholders of Vaxart (NASDAQ:VXRT) are in the black over 5 years, those who bought a week ago aren't so fortunate ...
Millennium Management LLC Has $2.66 Million Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT)
MarketBeat - 16 Oct 2024Millennium Management LLC Has $2.66 Million Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) ...
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
Benzinga - 15 Aug 2024Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside ...
Vaxart (VXRT) Sets Q3 2024 Earnings Call for November 13: Key Updates Coming | VXRT Stock News
StockTitan - 07 Nov 2024Vaxart (VXRT) Sets Q3 2024 Earnings Call for November 13: Key Updates Coming | VXRT Stock News ...
Vaxart Announces $40 Million Underwritten Offering of Common Stock | VXRT Stock News
StockTitan - 13 Jun 2024Vaxart Announces $40 Million Underwritten Offering of Common Stock | VXRT Stock News ...
While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
Yahoo Finance - 22 Jun 2024While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most ...
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
StockTitan - 24 Oct 2024Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024 ...
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance - 30 Aug 2024Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ...
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
StockTitan - 30 Sep 2024Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate ...